Hawkins (NASDAQ:HWKN - Get Free Report) is anticipated to announce its Q2 2027 results after the market closes on Monday, October 26th. Analysts expect Hawkins to post earnings of $1.19 per share and revenue of $302.70 million for the quarter. Individuals can check the company's upcoming Q2 2027 earnings summary page for the latest details on the call scheduled for Monday, October 26, 2026 at 4:10 PM ET.
Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing analysts' consensus estimates of $1.39 by ($0.04). Hawkins had a return on equity of 15.42% and a net margin of 7.29%. The business had revenue of $315.68 million for the quarter, compared to analyst estimates of $313.42 million. On average, analysts expect Hawkins to post $4.07 EPS for the current fiscal year and $4.80 EPS for the next fiscal year.
Hawkins Stock Performance
Shares of Hawkins stock opened at $131.66 on Monday. Hawkins has a 1 year low of $116.04 and a 1 year high of $174.12. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.54 and a current ratio of 2.27. The company has a market capitalization of $2.75 billion, a P/E ratio of 34.11, a PEG ratio of 2.69 and a beta of 0.74. The company's fifty day moving average is $126.13 and its two-hundred day moving average is $142.53.
Hawkins Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Friday, August 14th were issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, August 14th. Hawkins's dividend payout ratio is presently 20.73%.
Insider Buying and Selling
In other Hawkins news, CFO Jeffrey Oldenkamp bought 1,290 shares of the business's stock in a transaction dated Thursday, August 27th. The stock was acquired at an average cost of $119.00 per share, with a total value of $153,510.00. Following the purchase, the chief financial officer owned 104,223 shares in the company, valued at approximately $12,402,537. This represents a 1.25% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Douglas Lange purchased 910 shares of Hawkins stock in a transaction dated Tuesday, August 25th. The stock was acquired at an average cost of $118.75 per share, with a total value of $108,062.50. Following the completion of the acquisition, the vice president directly owned 28,169 shares in the company, valued at approximately $3,345,068.75. This trade represents a 3.34% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 3.70% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on HWKN shares. BWS Financial reiterated a "buy" rating and set a $200.00 target price on shares of Hawkins in a research note on Monday, August 3rd. Zacks Research lowered Hawkins from a "hold" rating to a "strong sell" rating in a report on Tuesday, August 4th. Barclays set a $141.00 price target on Hawkins and gave the stock an "equal weight" rating in a report on Tuesday, October 13th. Finally, Weiss Ratings upgraded Hawkins from a "hold (c)" rating to a "hold (c+)" rating in a research report on Monday, September 21st. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Hawkins presently has an average rating of "Hold" and a consensus price target of $170.50.
Check Out Our Latest Analysis on HWKN
Hawkins Company Profile
(
Get Free Report)
Hawkins, Inc NASDAQ: HWKN is a chemical manufacturer and distributor headquartered in Roseville, Minnesota. Founded in 1938, the company supplies products and services to municipal water and wastewater treatment providers, industrial businesses, agricultural customers, and health and nutrition companies.
Hawkins' water treatment offerings include chemicals such as liquid chlorine, aluminum sulfate, ferric chloride, potassium permanganate, phosphates, and polymers. The company also provides chemical blending, custom manufacturing, equipment, technical support, and related services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.